Pfizer Inc.
The United States has added a second COVID-19 vaccine to its arsenal, with the Food and Drug Administration authorizing an emergency rollout of the vaccine developed by Moderna Inc. and the National Institutes of Health. This move marks the world's first authorization for Moderna's shots and
Pfizer Inc.
California's divergent governmental responses are exemplified in the Southern California oceanside city of Manhattan Beach, where residents are encouraged to shop and engage in outdoor activities while the state is under a broad shutdown order to slow record-breaking coronavirus cases. Mayor Suzanne Hadley stated that the city'
Pfizer Inc.
The European Medicines Agency has fallen victim to a cyber attack, resulting in the theft of COVID-19 vaccine data. The agency, responsible for authorizing vaccine use across Europe, has access to trial and safety data from pharmaceutical companies Pfizer and Moderna. Pfizer, whose vaccine is in use in the UK,
Pfizer Inc.
The Royal Bank of Canada's chief executive, Dave McKay, is cautioning that the country may still face economic challenges despite promising COVID-19 vaccine candidates. McKay warned that the economy could suffer due to the emergence of a second wave of the pandemic, projecting a decline in economic growth
Pfizer Inc.
The Pfizer/BioNTech Covid vaccine, which has an efficacy of almost 95%, has been authorized by the UK medicines regulator, making the UK the first western country to license a vaccine against the disease. The UK has 40m doses of this vaccine on order. The vaccine works by introducing into
COVID-19 vaccines
Major U.S. stock markets closed Friday with notable gains as investors responded to encouraging news on the Pfizer coronavirus vaccine, along with growing optimism about economic recovery. The Dow Jones Industrial Average, despite a brief dip, ended the week up by 37 points, or 0.13%, at 29,910.
COVID-19 vaccines
Investors welcomed further progress on the development of a coronavirus vaccine, but were hard-pressed to ignore rising infection rates and curbs on businesses that could hamper an economic recovery. Stock futures rose Monday as pharmaceutical companies AstraZeneca and Pfizer announced positive results from late-stage trials of their respective vaccines. Meanwhile,
Pfizer Inc.
Maine's public health officials, led by Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, are finalizing plans to distribute COVID-19 vaccines to the state's 1.3 million residents as soon as mid-December. The vaccine rollout, which will involve the National Guard,
Pfizer Inc.
Scientists at Oxford University have made a significant breakthrough in their Covid-19 vaccine development, with phase two data showing that the vaccine triggers a robust immune response in healthy adults aged 56-69 and people over 70. This is a critical finding, as older adults are at increased risk of severe
Pfizer Inc.
Monday's price swings in shares of travel and entertainment companies showed traders' optimism about a COVID-19 vaccine, but a deeper dive into real estate investment trusts (REITs) reveals a potential opportunity for investors. With many Americans likely to return to their offices and workplaces after the pandemic,
Pfizer Inc.
Pharmaceutical firm Pfizer has announced its COVID-19 vaccine, developed in partnership with BioNTech, has shown more than 90% effectiveness in preventing people from developing the disease. The announcement comes after an interim analysis of data from a trial involving 43,500 people in six countries, with no safety concerns raised.
Pharmaceutical industry
Nearly 60,000 workers in the United States and Europe received pink slips yesterday as more than half a dozen companies announced significant job cuts in response to a sluggish global economy. The layoffs, which included employees at blue-chip firms like Pfizer Inc. and Caterpillar Inc., have sparked concerns about
